• D. BarskiEmail author
  • T. Otto


Cystitis describes a clinical syndrome of dysuria, frequency, urgency, occasional suprapubic pain, usually associated with urinary tract infection (UTI), an inflammatory response of the urothelium to bacterial invasion with bacteriuria, and pyuria. UTI affects men and women of all ages. The prevalence in young women is 30 times higher than in men. Almost half of all women experience a UTI during their lifetime [3]. However, with increasing age, the ratio of women to men with bacteriuria progressively decreases.


Urinary Tract Infection Interstitial Cystitis Neisseria Gonorrhoeae Recurrent Urinary Tract Infection Renal Scarring 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287:2701–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Brandström P, Jodal U, Sillén U, Hansson S. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. J Pediatr Urol. 2011;7:594–600.PubMedCrossRefGoogle Scholar
  3. 3.
    Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–15.PubMedCrossRefGoogle Scholar
  4. 4.
    Grabe M, Bartoletti R, Bjerklund-Johansen TE, et al. EAU Guidelines on Urological Infections Update 2014, published online on
  5. 5.
    Johansen TE, Cek M, Naber KG, et al. Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents. 2006;28 Suppl 1:S91–107.PubMedCrossRefGoogle Scholar
  6. 6.
    Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54:1164–75.PubMedCrossRefGoogle Scholar
  7. 7.
    Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113(Suppl 1A):14S–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Stamm WE, Counts GW, Wagner KF, et al. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med. 1980;92:770–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31 Suppl 1:S68–78.PubMedCrossRefGoogle Scholar
  10. 10.
    Wagenlehner FM, Schmiemann G, Hoyme U, et al. National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients. Urologe A. 2011;50:153–69.PubMedCrossRefGoogle Scholar
  11. 11.
    Wagenlehner FM, van Oostrum E, Tenke P, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63:521–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Wein AJ, Kavoussi LR, et al. Campbell-Walsh urology. 9th ed. 2007, Chapter 8, Saunders Elsevier, Philadelphia, PA 19103-2899, ISBN 10: 0-7216-0798-5Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of UrologyLukas HospitalNeussGermany

Personalised recommendations